Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · BIOMERICA INC (BMRA)

Biomerica director David Moatazedi will not stand for re-election in December 2026

Neutral Impact 2 of 5 leadership Written later

Biomerica director David Moatazedi told the board on October 12, 2026 that he will not stand for re-election at the company's 2026 Annual Meeting of Stockholders, scheduled for December 11, 2026. The company said the decision was not the result of any dispute or disagreement with the company or the board. Moatazedi has served on the board since December 2022 and chairs the Compensation Committee.

Key points

  • Moatazedi informed the board on October 12, 2026 of his decision not to seek re-election
  • The 2026 Annual Meeting of Stockholders is set for December 11, 2026
  • Moatazedi chairs the Compensation Committee and also serves on the Nominating and Corporate Governance and Audit Committees
  • The filing states the departure was not due to any dispute or disagreement with the company or the board

The filing

CompanyBIOMERICA INC (BMRA)
Form8-K, current report
Filed with the SECOct 15, 2026, 5:00 PM ET
Accession number0001493152-26-047270

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.